Strategic Development of an Immunotoxin for the Treatment of Glioblastoma and Other Tumours Expressing the Calcitonin Receptor
New strategies aimed at treatment of glioblastoma are frequently proposed to overcome poor prognosis. Recently, research has focused on glioma stem cells (GSCs), some quiescent, which drive expansion of glioblastoma and provide the complexity and heterogeneity of the tumour hierarchy. Targeting quie...
Main Authors: | Pragya Gupta, David L. Hare, Peter J. Wookey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2347 |
Similar Items
-
Calcitonin receptor expression in medullary thyroid carcinoma
by: Virginia Cappagli, et al.
Published: (2017-09-01) -
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues
by: Benjamin Wende, et al.
Published: (2023-02-01) -
Mice Lacking the Calcitonin Receptor Do Not Display Improved Bone Healing
by: Jessika Appelt, et al.
Published: (2021-09-01) -
Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors
by: Sangmin Lee
Published: (2021-09-01) -
Hsp70 and Calcitonin Receptor Protein in Extracellular Vesicles from Glioblastoma Multiforme: Biomarkers with Putative Roles in Carcinogenesis and Potential for Differentiating Tumor Types
by: Giusi Alberti, et al.
Published: (2024-03-01)